Related Experiment Video
Updated: Nov 23, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor
Jianguang Zhang1, Huifang Zheng2, Yong Diao3
1School of Medicine, Huaqiao University, Quanzhou 362021, Fujian, China. 1601116007@hqu.edu.cn.
Abstract:
Natural killer (NK) cells are innate immune cells that can be activated rapidly to target abnormal and virus-infected cells without prior sensitization. With significant advancements in cell biology technologies, many NK cell lines have been established. Among these cell lines, NK-92 cells are not only the most widely used but have also been approved for clinical applications. Additionally, chimeric antigen receptor-modified NK-92 cells (CAR-NK-92 cells) have shown strong antitumor effects. In this review, we summarize established human NK cell lines and their biological characteristics, and highlight the applications of NK-92 cells and CAR-NK-92 cells in tumor immunotherapy.
Insights
Natural killer (NK) cells are key innate immune cells. This review highlights NK-92 and CAR-NK-92 cells for their significant roles and applications in tumor immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial innate immune cells with rapid cytotoxic capabilities against abnormal and infected cells.
- Advancements in cell biology have led to the establishment of various NK cell lines for research and therapeutic development.
- NK-92 cells are a prominent human NK cell line, widely utilized and approved for clinical applications.
Purpose of the Study:
- To review established human NK cell lines and their biological characteristics.
- To highlight the therapeutic potential and applications of NK-92 cells in cancer immunotherapy.
- To discuss the advancements and antitumor effects of chimeric antigen receptor-modified NK-92 (CAR-NK-92) cells.
Main Methods:
- Literature review of established human NK cell lines.
- Analysis of biological characteristics of NK cell lines, focusing on NK-92.
- Examination of preclinical and clinical data on NK-92 and CAR-NK-92 cell applications in tumor immunotherapy.
Main Results:
- NK-92 cells are a well-characterized and clinically approved NK cell line.
- CAR-NK-92 cells demonstrate potent antitumor activity, enhancing the therapeutic efficacy of NK cells.
- Various NK cell lines offer distinct advantages for different research and therapeutic contexts.
Conclusions:
- NK-92 and CAR-NK-92 cells represent promising tools for advancing tumor immunotherapy.
- Further research into NK cell line applications can lead to novel cancer treatment strategies.
- The clinical approval and demonstrated efficacy of NK-92 cells underscore their importance in the field.
More Related Videos
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
11:02Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies
There are several types of targeted therapies against...